Clinical trial
Manipulation of Visceral Sensitivity and Immune System in IBS
NCT00418340 · London North West Healthcare NHS Trust, Other · Unknown status
Key facts
| NCT number | NCT00418340 |
|---|---|
| Title | Manipulation of Visceral Sensitivity and Immune System in IBS |
| Official title | Bacteria and Cytokines as Factors Modulating Visceral Afferent Processing in Irritable Bowel Syndrome: Manipulation of Intestinal Bacteria and Mucosal Cytokines by Probiotic Therapy and the Effect on Visceral Hypersensitivity |
| Lead sponsor | London North West Healthcare NHS Trust, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | probiotic (bacterial/dietary supplement) |
| Enrollment | 10 |
| Start date | Dec 1, 2007 |
| First posted | Jan 4, 2007 |
| Last update posted | Nov 16, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: